World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 2 October 2017
Main ID:  ISRCTN23393504
Date of registration: 25/08/2017
Prospective Registration: No
Primary sponsor: Singapore National Eye Centre
Public title: Randomized controlled trial evaluating an incentive-based community eye-care programme
Scientific title: Randomized controlled trial evaluating an incentive-based community eye-care programme for elderly with visual impairment
Date of first enrolment: 01/06/2014
Target sample size: 140
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN23393504
Study type:  Interventional
Study design:  Randomised controlled study (Quality of life)  
Phase: 
Countries of recruitment
Singapore
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Anna    Tan
Address:  11 Third Hospital Ave 168751 Singapore Singapore
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Over 21 years of age
2. The ability to speak English and/or Mandarin
3. Adequate hearing with/without hearing aids to respond to normal conversation
4. Not currently undergoing regular assessment/care with an ophthalmologist (at least yearly)
5. The ability to undergo visual acuity testing and provide reliable results
6. Visual acuity of 6/12 or worse in either eye after best correction

Exclusion criteria: Absence of the inclusion criteria and any other contraindication(s) as indicated by the general practitioner responsible for the participant

Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Visual impairment
Eye Diseases
Visual impairment including blindness (binocular or monocular)
Intervention(s)
Eligible participants were approached for informed consent and after they agreed to participate, they were randomised into 2 arms with a 1:1 ratio, either in the intervention arm where they received the ICS or the UC arm. Randomisation was performed by a random allocation sequence that was generated by a computer with no blocks or restrictions, and implemented by concealing the number-coded treatment within sealed envelopes until just before the procedure. After a potential participant was enrolled by the investigators and had given informed consent, a research coordinator performed assigned the participants to their groups after opening the sealed envelope. Due to the nature of the intervention, participants and researchers were unable to be masked to group assignment.

The usual stand of care (UC) after community eye screening was to provide a GP referral letter and advice to attend a tertiary eye care facility most accessible to them. In addition to the UC, those assigned to the ICS also received social and financial support to incentivise and improve compliance. All ICS participants were assisted with scheduling their tertiary care appointments, given telephone reminders, provided once-off transportation allowance and subsidy for their first tertiary eye-care consultation - while participants with mobility issues were assisted by volunteers. A medical social worker was also involved for the suitability of continuing financial support for further follow-up under various government schemes.
Primary Outcome(s)
Uptake of tertiary referral, measured using attendance to tertiary hospital at 3 months
Secondary Outcome(s)
1. Visual acuity, measured on Snellen chart at 3 months
2. Vision-related quality of life (VRQoL), assessed using the 28-item Impact of Vision Impairment (IVI) questionnaire at baseline and at 3 months
Secondary ID(s)
R1102/4/2014
Source(s) of Monetary Support
Singapore National Eye Centre
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history